论文部分内容阅读
目的观察厄贝沙坦与氢氯噻嗪联合治疗原发性高血压病的临床疗效。方法 120例原发性高血压病患者,随机分为治疗组60例,给予厄贝沙坦联合氢氯噻嗪治疗;对照组60例,单用厄贝沙坦治疗。疗程均为12周。结果总有效率治疗组91.7%,对照组76.7%,两组比较差异有统计学意义(P<0.05)。结论厄贝沙坦联合氢氯噻嗪治疗原发性高血压,疗效优于单用厄贝沙坦。
Objective To observe the clinical efficacy of irbesartan combined with hydrochlorothiazide in the treatment of essential hypertension. Methods A total of 120 patients with essential hypertension were randomly divided into treatment group (60 cases) and irbesartan combined with hydrochlorothiazide (60 cases). The control group (60 cases) were treated with irbesartan alone. The course of treatment is 12 weeks. Results The total effective rate was 91.7% in the treatment group and 76.7% in the control group, with significant difference between the two groups (P <0.05). Conclusion Irbesartan combined with hydrochlorothiazide in the treatment of essential hypertension, the effect is superior to irbesartan alone.